Reduced-Dose Radiation Shows Durable Control - Takeaways - MDSpire
From the Journals

Reduced-Dose Radiation Shows Durable Control

Single-arm cohort findings contrast with interim results from NRG-HN005, underscoring ongoing uncertainty around treatment deintensification.

  • By

  • Andrea Surnit

  • May 8, 2026

  • 4 min

Share

  • 1

    Study on 60-Gy radiotherapy for HPV-associated oropharyngeal carcinoma.

  • 2

    Low locoregional recurrence of 3.4% at 5 years.

  • 3

    Overall survival of 92.4% reported.

  • 4

    Patients had favorable smoking histories, untreated situations.

  • 5

    Treatment duration was over six weeks, with concurrent weekly cisplatin.

  • 6

    Nodal stage significantly impacted progression-free survival.

  • 7

    Further studies on treatment deintensification recommended.

Original Source(s)

Reduced-Dose Radiation Shows Durable Control

  • by Andrea Surnit

  • May 8, 2026

Related Content

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation

Ergonomic Risk in Head and Neck Surgery

Study suggests intraoperative pain and risk rise with case complexity and duration.

Symptom Scores May Signal Neuropathy Risk

Early recovery symptom patterns may help clinicians identify which oropharyngeal cancer survivors warrant closer neurologic surveillance.